Stockreport

Citius Oncology rises after U.S. launch of Lymphir as a cancer treatment [Seeking Alpha]

Cardinal Health, Inc.  (CAH) 
Last cardinal health, inc. earnings: 2/6 06:55 am Check Earnings Report
US:NYSE Investor Relations: ir.cardinalhealth.com/home
PDF The drug was approved in August by the FDA. Under a deal between the company and Cardinal Health, the latter is an authorized distributor for the company, providing p [Read more]